THE SAFETY PROFILE OF DEFERASIROX REMAINS CONSISTENT AS NON-TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS APPROACH THE TARGET LIVER IRON CONCENTRATION OF < 3 MG FE/G DW FOR INTERRUPTING CHELATION
Author
Zhu, Z.
Karakas, Zeynep
Galanello, R.
Habr, D.
Cappellini, M.
Taher, A.
Porter, J.
Viprakasit, V.
Kattamis, A.
Chuncharunee, S.
Sutcharitchan, P.
Siritanaratkul, N.
Metadata
Show full item recordCollections
- Makale [92796]